LanZhou Foci Pharmaceutical Co.,Ltd. (SHE:002644)

Market Cap	4.24B
Revenue (ttm)	922.02M
Net Income (ttm)	61.06M
Shares Out	510.66M
EPS (ttm)	0.12
PE Ratio	69.40
Forward PE	n/a
Dividend	0.01 (0.14%)
Ex-Dividend Date	Jun 25, 2024

Volume	6,788,105
Average Volume	14,961,467
Open	8.70
Previous Close	8.49
Day's Range	8.29 - 8.70
52-Week Range	6.15 - 10.10
Beta	0.42
RSI	45.90
Earnings Date	Aug 26, 2025

About SHE:002644

LanZhou Foci Pharmaceutical Co.,Ltd., research and development, production, and sales of traditional chinese medicines and health products in China. The company offers its products in various dosage forms, including pills, tablets, granules, capsules, and gelatin under the Min Shan and Foci brands. It also engages in planting and selling of Chinese medicinal materials; processing and selling of Chinese herbal medicine pieces; and production and sales of medical devices such as protective masks. In addition, the company exports its products. Lan...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1929
• Employees: 1,362
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002644

Financial Performance

In 2024, SHE:002644's revenue was 980.23 million, a decrease of -15.73% compared to the previous year's 1.16 billion. Earnings were 60.07 million, a decrease of -10.60%.